Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Designing isolation guidelines for COVID-19 patients utilizing rapid antigen tests: a simulation study using viral dynamics models

Yong Dam Jeong, View ORCID ProfileKeisuke Ejima, Kwang Su Kim, Woo Joohyeon, View ORCID ProfileShoya Iwanami, Yasuhisa Fujita, Il Hyo Jung, Kenji Shibuya, Shingo Iwami, View ORCID ProfileAna I. Bento, Marco Ajelli
doi: https://doi.org/10.1101/2022.01.24.22269769
Yong Dam Jeong
1interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan
2Department of Mathematics, Pusan National University, Busan, South Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keisuke Ejima
3Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, IN, USA
4The Tokyo Foundation for Policy Research, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Keisuke Ejima
  • For correspondence: kejima@iu.edu iwami.iblab@bio.nagoya-u.ac.jp
Kwang Su Kim
1interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Woo Joohyeon
1interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shoya Iwanami
1interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shoya Iwanami
Yasuhisa Fujita
1interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Il Hyo Jung
2Department of Mathematics, Pusan National University, Busan, South Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenji Shibuya
4The Tokyo Foundation for Policy Research, Tokyo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shingo Iwami
1interdisciplinary Biology Laboratory (iBLab), Division of Biological Science, Graduate School of Science, Nagoya University, Nagoya, Japan
5Institute of Mathematics for Industry, Kyushu University, Fukuoka, Japan
6Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan
7NEXT-Ganken Program, Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan
8Science Groove Inc., Fukuoka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kejima@iu.edu iwami.iblab@bio.nagoya-u.ac.jp
Ana I. Bento
3Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, IN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ana I. Bento
Marco Ajelli
9Laboratory for Computational Epidemiology and Public Health, Department of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, IN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Appropriate isolation guidelines for COVID-19 patients are warranted. Currently, isolating for fixed time is adapted in most countries. However, given the variability in viral dynamics between patients, some patients may no longer be infectious by the end of isolation (thus they are redundantly isolated), whereas others may still be infectious. Utilizing viral test results to determine ending isolation would minimize both the risk of ending isolation of infectious patients and the burden due to redundant isolation of noninfectious patients. In our previous study, we proposed a computational framework using SARS-CoV-2 viral dynamics models to compute the risk and the burden of different isolation guidelines with PCR tests. In this study, we extend the computational framework to design isolation guidelines for COVID-19 patients utilizing rapid antigen tests. Time interval of tests and number of consecutive negative tests to minimize the risk and the burden of isolation were explored. Furthermore, the approach was extended for asymptomatic cases. We found the guideline should be designed considering various factors: the infectiousness threshold values, the detection limit of antigen tests, symptom presence, and an acceptable level of releasing infectious patients. Especially, when detection limit is higher than the infectiousness threshold values, more consecutive negative results are needed to ascertain loss of infectiousness. To control the risk of releasing of infectious individuals under certain levels, rapid antigen tests should be designed to have lower detection limits than infectiousness threshold values to minimize the length of prolonged isolation, and the length of prolonged isolation increases when the detection limit is higher than the infectiousness threshold values, even though the guidelines are optimized for given conditions.

Competing Interest Statement

M.A. has received research funding from Seqirus; the funding is not related to COVID-19. The other authors declare that they have no competing interests.

Funding Statement

This study was supported in part by The Tokyo Foundation for Policy Research (to K.E. and K.S.); Grants-in-Aid for JSPS Scientific Research (KAKENHI) Scientific Research B 18KT0018 (to S.IWAMI), 18H01139 (to S.IWAMI), 16H04845 (to S.IWAMI), Scientific Research in Innovative Areas 20H05042 (to S.IWAMI), 19H04839 (to S.IWAMI), 18H05103 (to S.IWAMI); AMED CREST 19gm1310002 (to S.IWAMI); AMED Japan Program for Infectious Diseases Research and Infrastructure, 20wm0325007h0001, 20wm0325004s0201, 20wm0325012s0301, 20wm0325015s0301 (to S.IWAMI); AMED Research Program on HIV/AIDS 19fk0410023s0101 (to S.IWAMI); AMED Research Program on Emerging and Re-emerging Infectious Diseases 19fk0108156h0001, 20fk0108140s0801 and 20fk0108413s0301 (to S.IWAMI); AMED Program for Basic and Clinical Research on Hepatitis 19fk0210036h0502 (to S.IWAMI); AMED Program on the Innovative Development and the Application of New Drugs for Hepatitis B 19fk0310114h0103 (to S.IWAMI); Moonshot R&D Grant Number JPMJMS2021 (to S.IWAMI) and JPMJMS2025 (to S.IWAMI); JST MIRAI (to S.IWAMI); Mitsui Life Social Welfare Foundation (to S.IWAMI); Shin-Nihon of Advanced Medical Research (to S.IWAMI); Suzuken Memorial Foundation (to S.IWAMI); Life Science Foundation of Japan (to S.IWAMI); SECOM Science and Technology Foundation (to S.IWAMI); The Japan Prize Foundation (to S.IWAMI); Foundation for the Fusion of Science and Technology (to S.IWAMI); the MIDAS Coordination Center (MIDASSUGP2020-6) by a grant from the National Institute of General Medical Science (3U24GM132013-02S2) (to K.E. and M.A.). The study does not necessarily represent the views of the funding agencies listed above.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study involves only openly available human data, which can be obtained from the original articles summarized in Table 1.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Competing Interest Statement: M.A. has received research funding from Seqirus; the funding is not related to COVID-19. The other authors declare that they have no competing interests.

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted January 25, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Designing isolation guidelines for COVID-19 patients utilizing rapid antigen tests: a simulation study using viral dynamics models
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Designing isolation guidelines for COVID-19 patients utilizing rapid antigen tests: a simulation study using viral dynamics models
Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, Woo Joohyeon, Shoya Iwanami, Yasuhisa Fujita, Il Hyo Jung, Kenji Shibuya, Shingo Iwami, Ana I. Bento, Marco Ajelli
medRxiv 2022.01.24.22269769; doi: https://doi.org/10.1101/2022.01.24.22269769
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Designing isolation guidelines for COVID-19 patients utilizing rapid antigen tests: a simulation study using viral dynamics models
Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, Woo Joohyeon, Shoya Iwanami, Yasuhisa Fujita, Il Hyo Jung, Kenji Shibuya, Shingo Iwami, Ana I. Bento, Marco Ajelli
medRxiv 2022.01.24.22269769; doi: https://doi.org/10.1101/2022.01.24.22269769

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (230)
  • Allergy and Immunology (507)
  • Anesthesia (111)
  • Cardiovascular Medicine (1256)
  • Dentistry and Oral Medicine (207)
  • Dermatology (148)
  • Emergency Medicine (283)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (537)
  • Epidemiology (10047)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2481)
  • Geriatric Medicine (239)
  • Health Economics (482)
  • Health Informatics (1652)
  • Health Policy (756)
  • Health Systems and Quality Improvement (638)
  • Hematology (250)
  • HIV/AIDS (536)
  • Infectious Diseases (except HIV/AIDS) (11888)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (255)
  • Medical Ethics (75)
  • Nephrology (269)
  • Neurology (2301)
  • Nursing (140)
  • Nutrition (354)
  • Obstetrics and Gynecology (458)
  • Occupational and Environmental Health (537)
  • Oncology (1257)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (326)
  • Pediatrics (737)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2294)
  • Public and Global Health (4850)
  • Radiology and Imaging (846)
  • Rehabilitation Medicine and Physical Therapy (493)
  • Respiratory Medicine (654)
  • Rheumatology (288)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (228)
  • Surgery (271)
  • Toxicology (44)
  • Transplantation (130)
  • Urology (100)